Treace Medical Correlations
| TMCI Stock | USD 5.00 0.63 11.19% |
The correlation of Treace Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Treace Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Treace Medical Concepts moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Modest diversification
The correlation between Treace Medical Concepts and NYA is 0.22 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Treace Medical Concepts and NYA in the same portfolio, assuming nothing else is changed.
Treace |
The ability to find closely correlated positions to Treace Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Treace Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Treace Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Treace Medical Concepts to buy it.
Moving together with Treace Stock
| 0.79 | AHG | Akso Health Group | PairCorr |
| 0.73 | XAIR | Beyond Air Financial Report 27th of June 2024 | PairCorr |
| 0.67 | CAH | Cardinal Health Fiscal Year End 20th of August 2024 | PairCorr |
| 0.69 | FONR | Fonar Earnings Call Tomorrow | PairCorr |
| 0.79 | CVS | CVS Health Corp | PairCorr |
| 0.8 | FNA | Paragon 28 | PairCorr |
| 0.8 | SSY | SunLink Health Systems | PairCorr |
| 0.64 | TFX | Teleflex Incorporated | PairCorr |
| 0.68 | XTNT | Xtant Medical Holdings | PairCorr |
| 0.71 | VMD | Viemed Healthcare | PairCorr |
Moving against Treace Stock
| 0.85 | THC | Tenet Healthcare Earnings Call This Week | PairCorr |
| 0.85 | JYNT | Joint Corp Earnings Call This Week | PairCorr |
| 0.82 | HAE | Haemonetics | PairCorr |
| 0.73 | RMD | ResMed Inc Financial Report 1st of August 2024 | PairCorr |
| 0.67 | LIVN | LivaNova PLC | PairCorr |
| 0.56 | GCTK | GlucoTrack | PairCorr |
| 0.54 | KIDS | Orthopediatrics Corp | PairCorr |
| 0.5 | ELMD | Electromed | PairCorr |
| 0.45 | ITGR | Integer Holdings Corp | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Treace Stock performing well and Treace Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Treace Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RXST | 2.52 | 0.06 | 0.06 | 0.11 | 2.64 | 5.17 | 12.20 | |||
| AXGN | 2.37 | (0.92) | 0.00 | (0.29) | 0.00 | 3.20 | 21.07 | |||
| LUNG | 3.02 | (0.77) | 0.00 | (0.42) | 0.00 | 4.69 | 29.06 | |||
| OFIX | 1.98 | (0.05) | 0.01 | 0.06 | 2.58 | 4.28 | 15.45 | |||
| KIDS | 2.45 | 0.06 | 0.05 | 0.12 | 2.66 | 6.44 | 17.32 | |||
| ITGR | 1.51 | 0.14 | 0.06 | 0.24 | 2.22 | 3.17 | 14.38 | |||
| CNMD | 1.70 | (0.23) | 0.00 | (0.12) | 0.00 | 2.96 | 15.54 | |||
| ESTA | 2.95 | 0.51 | 0.16 | 0.32 | 3.17 | 7.36 | 28.65 | |||
| SGHT | 3.06 | 0.27 | 0.08 | 0.27 | 3.68 | 6.69 | 20.95 | |||
| FNA | 3.49 | (1.05) | 0.00 | (0.34) | 0.00 | 7.78 | 31.62 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Treace Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Treace Medical Corporate Management
Elected by the shareholders, the Treace Medical's board of directors comprises two types of representatives: Treace Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Treace. The board's role is to monitor Treace Medical's management team and ensure that shareholders' interests are well served. Treace Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Treace Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shana Zink | Medical Affairs | Profile | |
| Julie Dewey | Chief Officer | Profile | |
| Scot JD | Chief Secretary | Profile | |
| Thomas Timbie | Independent Director | Profile | |
| John Treace | Founder CEO | Profile | |
| Sean Scanlan | Chief Officer | Profile | |
| Nathan Minnich | Senior Marketing | Profile |
Already Invested in Treace Medical Concepts?
The danger of trading Treace Medical Concepts is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Treace Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Treace Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Treace Medical Concepts is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Treace Medical Concepts information on this page should be used as a complementary analysis to other Treace Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Treace Stock analysis
When running Treace Medical's price analysis, check to measure Treace Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Treace Medical is operating at the current time. Most of Treace Medical's value examination focuses on studying past and present price action to predict the probability of Treace Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Treace Medical's price. Additionally, you may evaluate how the addition of Treace Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Treace Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.88) | Revenue Per Share 3.181 | Quarterly Revenue Growth 0.211 | Return On Assets (0.14) | Return On Equity (0.39) |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.